Cargando…
Efficacy and Safety of Switching from Low-Dose Statin to High-Intensity Statin for Primary Prevention in Type 2 Diabetes: A Randomized Controlled Trial
INTRODUCTION: Statin intensification is required in patients who have high-risk for cardiovascular events. However, it is unclear if this is needed in whom plasma LDL-C target was achieved with low-dose statin for primary prevention. We investigated the efficacy and safety of switching from low-dose...
Autores principales: | Thongtang, Nuntakorn, Piyapromdee, Jirasak, Tangkittikasem, Natthakan, Samaithongcharoen, Kittichai, Srikanchanawat, Nithiwat, Sriussadaporn, Sutin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038773/ https://www.ncbi.nlm.nih.gov/pubmed/32110075 http://dx.doi.org/10.2147/DMSO.S219496 |
Ejemplares similares
-
Effect of Switching from Low-Dose Simvastatin to High-Dose Atorvastatin on Glucose Homeostasis and Cognitive Function in Type 2 Diabetes
por: Thongtang, Nuntakorn, et al.
Publicado: (2020) -
Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients
por: Thongtang, Nuntakorn, et al.
Publicado: (2017) -
Withdrawal of sulfonylureas from patients with type 2 diabetes receiving long-term sulfonylurea and insulin combination therapy results in deterioration of glycemic control: a randomized controlled trial
por: Srivanichakorn, Weerachai, et al.
Publicado: (2015) -
Comparison of the efficacy and safety of intensive-dose and standard-dose statin treatment for stroke prevention: A meta-analysis
por: Wang, Juan, et al.
Publicado: (2016) -
Intensive statin therapy in India: Demonstrating efficacy and safety
por: Davidson, Michael H.
Publicado: (2016)